Exhibit 10.2


 


EQUITY FINANCING AGREEMENT


 


This EQUITY FINANCING AGREEMENT (the “Agreement”),
dated as of December 1, 2016 (the “Execution Date”), is entered into by and between Propanc Health Group Corporation,
a Delaware corporation with its principal executive office at 302, 6 Butler Street Camberwell, VIC 3124 Australia (the “Company”),
and GHS Investments LLC, a Nevada limited liability company, with offices at 200 Stonehinge Lane, Suite 3, Carle Place, NY 11514.
(the “Investor”).


 


RECITALS:


 


WHEREAS, the parties desire
that, upon the terms and subject to the conditions contained herein, the Investor shall invest up to Seven Million Dollars ($7,000,000)
from time to time over the course of twenty-four (24) months after an effective registration of the underlying shares to purchase
the Company’s common stock, par value $0.001 per share (the “Common Stock”);


 


WHEREAS, such investments
will be made in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933,
as amended (the “1933 Act”), and/or upon such other exemption from the registration requirements of the 1933
Act as may be available with respect to any or all of the investments in Common Stock to be made hereunder; and


 


WHEREAS, contemporaneously
with the execution and delivery of this Agreement, the parties hereto are executing and delivering a Registration Rights Agreement
substantially in the form attached hereto as Exhibit A (the “Registration Rights Agreement”) pursuant
to which the Company has agreed to provide certain registration rights under the 1933 Act, and the rules and regulations promulgated
thereunder, and applicable state securities laws.


 


NOW THEREFORE, in consideration
of the foregoing recitals, which shall be considered an integral part of this Agreement, the covenants and agreements set forth
hereafter, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Company
and the Investor hereby agree as follows:


 


SECTION I.


DEFINITIONS


 


For all purposes of and
under this Agreement, the following terms shall have the respective meanings below, and such meanings shall be equally applicable
to the singular and plural forms of such defined terms.


 


“1933 Act” shall
have the meaning set forth in the recitals.


 


“1934 Act” shall
mean the Securities Exchange Act of 1934, as amended, or any similar federal statute, and the rules and regulations of the SEC
thereunder, all as the same will then be in effect.


 


“Affiliate” shall
have the meaning set forth in Section 5.7.


 


“Agreement” shall
have the meaning set forth in the preamble.


 


“Articles of Incorporation”
shall have the meaning set forth in Section 4.3.


 


“By-laws” shall
have the meaning set forth in Section 4.3.


 




     


     


    

 


“Closing” shall
have the meaning set forth in Section 2.5.


 


“Closing Date”
shall have the meaning set forth in Section 2.5.


 


“Commitment” shall
have the meaning set forth in Section 2.1.


 


“Commitment Note”
shall have the meaning set forth in Section 2.8.


 


“Common Stock”
shall have the meaning set forth in the recitals.


 


“Control” or “Controls”
shall have the meaning set forth in Section 5.7.


 


“Effective Date”
shall mean the date the SEC declares effective under the 1933 Act the Registration Statement.


 


“Execution Date”
shall have the meaning set forth in the preamble.


 


“Indemnified Liabilities”
shall have the meaning set forth in Section 10.


 


“Indemnitees”
shall have the meaning set forth in Section 10.


 


“Indemnitor” shall
have the meaning set forth in Section 10.


 


“Initial Draw”
shall have the meaning set forth in Section 2.2.


 


“Investor” shall
have the meaning set forth in the preamble.


 


“Investor’s Delay”
shall have the meaning set forth in the Registration Rights Agreement.


 


“Market Price”
shall mean the average of the three (3) lowest volume weighted average prices of the Company’s Common Stock during the Pricing
Period.


 


“Material Adverse Effect”
shall have the meaning set forth in Section 4.1.


 


“Maximum Common Stock Issuance”
shall have the meaning set forth in Section 2.6.


 


“Open Period”
shall mean the period beginning on and including the Trading Day immediately following the Effective Date and ending on the earlier
to occur of (i) the date which is twenty four (24) months from the Effective Date; or (ii) termination of the Agreement in accordance
with Section 8.


 


“Pricing Period”
shall mean the ten (10) consecutive Trading Days immediately preceding the receipt of the applicable Put Notice.


 


“Principal Market”
shall mean the principal Trading Market on which the Common Stock is listed or quoted for trading on the date in question.


 


“Promissory Note”
means the promissory note substantially in the form attached hereto as Exhibit B, in exchange for which the Investor shall
fund the Initial Draw.


 




    	 	2	 



     


    

 


“Purchase Price”
shall mean eighty percent (80%) of the Market Price; provided that in any event the Purchase Price shall not be less than the Put
Floor.


 


“Put” shall have
the meaning set forth in Section 2.3.


 


“Put Amount” shall
have the meaning set forth in Section 2.3.


 


“Put Floor” shall
have the meaning set forth in Section 2.9.


 


“Put Notice” shall
mean a written notice substantially in the form attached hereto as Exhibit C sent to the Investor by the Company in connection
with a Put and stating the Put Amount in U.S. dollars that the Company intends to sell to the Investor pursuant to the terms of
the Agreement and stating the current number of Shares issued and outstanding on such date.


 


“Put Notice Date”
shall mean the Trading Day, as set forth below, on which the Investor receives a Put Notice.


 


“Put Shares Due”
shall mean, with respect to each Put, the number of Shares equal to the quotient of (i) the Put Amount for such Put, divided by
(ii) the Purchase Price for such Put, as set forth in a Put Settlement Sheet substantially in the form attached hereto as Exhibit
D sent to the Company by the Investor on the Put Notice Date.


 


“Registrable Securities”
shall have the meaning set forth in the Registration Rights Agreement.


 


“Registration Rights Agreement”
shall have the meaning set forth in the recitals.


 


“Registration Statement”
means a registration statement of the Company filed under the 1933 Act pursuant to the Registration Rights Agreement covering the
Registrable Securities.


 


“Related Party”
shall have the meaning set forth in Section 5.7.


 


“Resolutions”
shall have the meaning set forth in Section 7.4.


 


“SEC” shall mean
the U.S. Securities and Exchange Commission.


 


“SEC Documents”
shall have the meaning set forth in Section 4.6.


 


“Securities” shall
mean the shares of Common Stock issued pursuant to the terms of this Agreement.


 


“Shares” shall
mean the shares of the Company’s Common Stock.


 


“Short Sales”
shall mean all “short sales” as defined in Rule 200 of Regulation SHO under the 1934 Act.


 


“Subsidiaries”
shall have the meaning set forth in Section 4.1.


 


“Trading Day”
shall mean any day on which the Principal Market for the Common Stock is open for trading, from the hours of 9:30 am until 4:00
pm.


 




    	 	3	 



     


    

 


“Trading Market”
shall mean any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question:
the New York Stock Exchange, the NYSE Amex, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
the OTC Markets or the OTC Bulletin Board, whichever is the principal market.


 


“Trading Period”
shall have the meaning set forth in Section 2.5.


 


“Trading Period Shares”
shall have the meaning set forth in Section 2.5.


 


“Transaction Documents”
shall mean this Agreement, the Commitment Note, the Promissory Note, the Registration Rights Agreement and supporting documents
between the Company and the Investor as of the date hereof.


 


“VWAP” shall have
the meaning set forth in Section 2.5.


 


SECTION II


PURCHASE AND SALE OF COMMON STOCK


 


2.1           PURCHASE
AND SALE OF COMMON STOCK. Subject to the terms and conditions set forth herein, the Company shall issue and sell to the Investor,
and the Investor shall purchase from the Company, up to that number of Shares having an aggregate Purchase Price of Seven Million
Dollars ($7,000,000) (the “Commitment”).


 


2.2           INITIAL
DRAW: Promptly upon the filing of the Registration Statement on or before the thirtieth (30th) calendar day following
the date hereof, an initial two hundred and fifty thousand dollars ($250,000) shall be paid by the Investor to the Company in immediately
available funds (the “Initial Draw”), and the Company shall deliver to the Investor the Promissory Note. The
Shares underlying the Promissory Note shall be included in the Registration Statement pursuant to the Registration Rights Agreement.


 


2.3           DELIVERY
OF PUT NOTICES. Subject to the terms and conditions herein, at any time and from time to time during the Open Period, the Company
may, in its sole discretion, deliver a Put Notice to the Investor which states the dollar amount (designated in U.S. Dollars) of
Shares (the “Put Amount”), which the Company intends to sell to the Investor on a Closing Date (each, a “Put”
and collectively, the “Puts”). The timing and amounts of any Puts shall be at the sole discretion of the Company.
Prior to any Closing, the Company may, in its sole discretion, withdraw any Put Notice. Unless approved by the Investor, (i) the
maximum dollar amount of any Put shall not exceed two (2) times the average of the daily trading dollar volume for the Company’s
Common Stock during the ten (10) Trading Days preceding the Put Notice Date, (ii) the minimum Put Amount in any Put Notice is twenty
five thousand dollars ($25,000), and (iii) the maximum Put Amount in any Put Notice is three hundred thousand dollars ($300,000).
The price of the Shares sold to the Investor in each Put shall be the Purchase Price set forth in the applicable Put Notice. During
the Open Period, the Company shall not be entitled to submit a Put Notice until after the previous Closing has been completed or
the previous Put Notice has been withdrawn. There will be a minimum of ten (10) Trading Days between Put Notices unless agreed
to otherwise by the Investor in writing.


 


2.4           CONDITIONS
TO INVESTOR’S OBLIGATION TO PURCHASE SHARES. Notwithstanding anything to the contrary in this Agreement, the Company
shall not be entitled to deliver a Put Notice and the Investor shall not be obligated to purchase any Shares at a Closing unless
each of the following conditions are satisfied:


 




    	 	4	 



     


    

 


		i.	a Registration Statement shall have been declared effective
and shall remain effective and available for the resale of the Registrable Securities in accordance with the Registration Rights
Agreement, at all times until the Closing with respect to the subject Put Notice;



 


		ii.	at all times during the period beginning on the related
Put Notice Date and ending on and including the related Closing Date, the Common Stock shall have been listed or quoted for trading
on the Principal Market, and the Common Stock shall not have been suspended from trading thereon for a period of two (2) consecutive
Trading Days during the thirty (30) day period preceding the Put Notice Date and the Company shall not have been notified of any
pending or threatened proceeding or other action to suspend the trading of the Common Stock;



 


		iii.	the Company has complied with its obligations and is otherwise
not in breach of or in default under, this Agreement, the Registration Rights Agreement or any other Transaction Document, which
has not been cured prior to the Put Notice Date;



 


		iv.	no injunction shall have been issued and remain in force,
or action commenced by a governmental authority which has not been stayed or abandoned, prohibiting the purchase or the issuance
of the Securities; and



 


		v.	the issuance of the Securities will not violate any shareholder
approval requirements of the Principal Market.



 


If any of the events described
in clauses (i) through (v) above occurs during a Pricing Period, then the Investor shall have no obligation to purchase the Put
Amount of Common Stock set forth in the applicable Put Notice.


 


2.5           MECHANICS
OF PURCHASE OF SHARES BY INVESTOR. Subject to satisfaction of the conditions set forth in Sections 2.4, 6 and 7 of this Agreement,
the Closing of a Put (each, a “Closing” and collectively, the “Closings”) shall occur upon
the first Trading Day (the “Closing Date”) following the receipt by Investor of a Put Notice. On each Closing
Date, the Company shall cause the Transfer Agent to electronically transmit the applicable Put Shares Due by crediting the account
of the Investor’s broker with DTC through its Deposit Withdrawal Agent Commission (“DWAC”) system (or, if DWAC
is not available for the Put Shares Due on the applicable Closing Date, the Company shall cause the Transfer Agent to deliver Investor
a certificate representing the Put Shares Due), against delivery by the Investor of the Put Amount specified in the Put Notice
to an account designated by the Company or, at the Company’s option, by reduction in an amount equal to the Put Amount of
the amounts owed to the Investor under the Promissory Note. If the Put Shares Due are received and approved by the Investor's broker
by 9:30 am EST, the Investor shall make payment to the Company’s designated account by wire transfer of immediately available
funds or, if the Put Shares Due are received and receipt is confirmed by the Investor’s broker after 9:30 am EST, the Investor
shall make payment to the Company’s designated account by wire transfer of next day available funds. In addition, on or prior
to such Closing Date, each of the Company and Investor shall deliver to each other all documents, instruments and writings required
to be delivered or reasonably requested by either of them pursuant to this Agreement in order to implement and effect the transactions
contemplated herein. In the event that (i) the average of the three (3) lowest volume-weighted average prices (the “VWAP”)
of the Company’s Common Stock during the ten (10) trading days following a Put Notice (the “Trading Period”)
is less than 85% of the Market Price used to determine the Purchase Price in connection with the Put and (ii) as of the end of
such Trading Period the Investor holds Shares issued pursuant to such Put Notice (the “Trading Period Shares”),
then the Company shall issue such additional Shares as may be necessary to adjust the Purchase Price for that portion of the Put
represented by the Trading Period Shares to equal the VWAP during the Trading Period.


 




    	 	5	 



     


    

 


2.6           OVERALL
LIMIT ON COMMON STOCK ISSUABLE. Notwithstanding anything contained herein to the contrary, if during the Open Period the Company
becomes listed on an exchange which limits the number of shares of Common Stock that may be issued without shareholder approval,
then the number of Shares issuable by the Company and purchasable by the Investor, shall not exceed that number of Shares that
may be issuable without such shareholder approval (the “Maximum Common Stock Issuance”). If such issuance of
Shares could cause a delisting on the Principal Market, then the Company shall be under no obligation to issue Shares in excess
of the Maximum Common Stock Issuance unless and until such issuance shall first be approved by the Company’s shareholders
in accordance with applicable law and the By-laws and the Articles of Incorporation of the Company. The parties understand and
agree that the Company’s failure to seek, in its sole discretion, or obtain such shareholder approval shall in no way adversely
affect the validity and due authorization of the issuance and sale of Securities or the Investor’s obligation in accordance
with the terms and conditions hereof to purchase a number of Shares in the aggregate up to the Maximum Common Stock Issuance, and
that such approval pertains only to the applicability of the Maximum Common Stock Issuance limitation provided in this Section
2.6.


 


2.7           LIMITATION
ON AMOUNT OF OWNERSHIP. Notwithstanding anything to the contrary in this Agreement, in no event shall the Investor be entitled
to purchase that number of Shares, which when added to the sum of the number of shares of Common Stock beneficially owned (as such
term is defined under Section 13(d) and Rule 13d-3 of the 1934 Act), by the Investor, would exceed 9.99% of the number of shares
of Common Stock outstanding on the Closing Date, as determined in accordance with Rule 13d-1(j) of the 1934 Act.


 


2.8           COMMITMENT
FEE. Upon the execution of this Agreement, the Company shall issue the Investor a $20,000 promissory note, payable 6 months
from issuance (the “Commitment Note”). Upon the Closing of each Put, the Company shall pay three quarters of
one percent (0.75%) of the applicable Put Amount to the Investor, which amount shall be deducted by the Investor from each wire.
The Commitment Note shall be deemed earned upon the execution of this Agreement.


 


2.9           PUT
FLOOR. Notwithstanding anything to the contrary herein, the minimum Purchase Price in any Put shall be $0.01 (the “Put
Floor”). The Parties may, but shall not be obligated to, agree in writing to render the Put Floor inoperative where the
Company’s Common Stock has traded at or below $0.01 for any two (2) Trading Days during a Pricing Period.


 


SECTION III


 


INVESTOR’S REPRESENTATIONS, WARRANTIES
AND COVENANTS


 


The Investor represents
and warrants to the Company, and covenants, that:


 


3.1           SOPHISTICATED
INVESTOR. The Investor has, by reason of its business and financial experience, such knowledge, sophistication and experience
in financial and business matters and in making investment decisions of this type that it is capable of (I) evaluating the merits
and risks of an investment in the Securities and making an informed investment decision; (II) protecting its own interest; and
(III) bearing the economic risk of such investment for an indefinite period of time.


 




    	 	6	 



     


    

 


3.2           AUTHORIZATION;
ENFORCEMENT. The execution and delivery of the Transaction Documents and performance by Investor of the transactions contemplated
thereby have been duly and validly authorized by all necessary limited liability company action. This Agreement and the other Transaction
Documents to which it is a party have been duly executed and delivered on behalf of the Investor and is a valid and binding agreement
of the Investor enforceable against the Investor in accordance with its terms, subject as to enforceability to general principles
of equity and to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to,
or affecting generally, the enforcement of applicable creditors’ rights and remedies.


 


3.3           SECTION
9 OF THE 1934 ACT. During the term of this Agreement, the Investor will comply with the provisions of Section 9 of the 1934
Act, and the rules promulgated thereunder, with respect to transactions involving the Common Stock. The Investor agrees not to
sell the Company’s stock short, either directly or indirectly through its affiliates, principals or advisors during the term
of this Agreement.


 


3.4           ACCREDITED
INVESTOR. At the time Investor was offered the Securities, Investor was, and as of the date hereof it is, and as of each Closing
it will be, an “Accredited Investor” as that term is defined in Rule 501(a) of Regulation D of the 1933 Act.


 


3.5           GENERAL
SOLICITATION. Investor is not, to Investor’s knowledge, purchasing the Securities as a result of any advertisement, article,
notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over
television or radio or presented at any seminar or any other general solicitation or general advertisement.


 


3.6           GOVERNMENTAL
REVIEW. Investor understands that no United States federal or state agency or any other government or governmental agency has
passed upon or made any recommendation or endorsement of the Securities or an investment therein.


 


3.7           RELIANCE
ON EXEMPTIONS. Investor understands that the Securities are being offered and sold to it in reliance upon specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying upon the
truth and accuracy of, and Investor’s compliance with, the representations, warranties, agreements, acknowledgments and understandings
of Investor set forth herein in order to determine the availability of such exemptions and the eligibility of Investor to acquire
the Securities.


 


3.8           PRINCIPAL
PLACE OF BUSINESS. Investor’s principal place of business is correctly set forth in Section 11.7 hereof.


 


3.9           NO
CONFLICTS. The execution, delivery and performance of the Transaction Documents by the Investor and the consummation by the
Investor of the transactions contemplated hereby and thereby will not result in a violation of the Investor’s Partnership
Agreement or any other organizational documents of the Investor.


 


3.10         OPPORTUNITY
TO DISCUSS. The Investor acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Documents. The Investor has received all materials relating to the Company’s business,
finance and operations which it has requested, and has had the opportunity to obtain such additional information that the Company
possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with
respect to the Securities. The Investor has had an opportunity to discuss the business, management and financial affairs of the
Company with the Company’s management.


 




    	 	7	 



     


    

 


3.11         INVESTMENT
PURPOSES. Investor understands that the Securities are “restricted securities” and have not been registered under
the 1933 Act or any applicable state securities law. The Investor is purchasing the Securities for its own account for investment
purposes and not with a view towards distribution and agrees to resell or otherwise dispose of the Securities solely in accordance
with the registration provisions of the 1933 Act (or pursuant to an exemption from such registration provisions; provided that
the Company shall have received an opinion of its counsel that shall be in form, substance and scope customary for counsel in comparable
transactions to the effect that the Securities to be sold or transferred may be sold or transferred pursuant to an exemption from
such registration). Investor is acquiring the Securities hereunder in the ordinary course of its business.


 


3.12         NO
REGISTRATION AS A DEALER. The Investor is not required to be registered as a “dealer” under the 1934 Act, either
as a result of its execution and performance of its obligations under this Agreement, any other Transaction Document, or otherwise.


 


3.13         NO
BROKERS. No brokerage or finder’s fees or commissions are or will be payable by Investor or its Affiliates to any broker,
financial advisor or consultant, placement agent, investment banker, bank or other person with respect to the transactions contemplated
by the Transaction Documents.


 


3.14         GOOD
STANDING. The Investor is a limited liability company, duly organized, validly existing and in good standing in the State of
Nevada.


 


3.15         TAX
LIABILITIES. The Investor understands that it is liable for its own tax liabilities.


 


3.16         REGULATION
M. The Investor will comply with Regulation M under the 1934 Act, if applicable.


 


3.17         No
Short Sales. The Investor covenants that neither it nor its Affiliates will execute or effect any Short Sales during
the period commencing on the Execution Date and continuing through the termination of this Agreement.


 


SECTION IV


REPRESENTATIONS AND WARRANTIES OF THE COMPANY


 


Except as set forth in
the Schedules attached hereto, or as disclosed on the Company’s SEC Documents, the Company represents and warrants to the
Investor that:


 


4.1           ORGANIZATION
AND QUALIFICATION. The Company is a corporation duly organized and validly existing in good standing under the laws of the
State of Delaware, and has the requisite corporate power and authorization to own its properties and to carry on its business as
now being conducted. Both the Company and the companies it owns or controls (“Subsidiaries”) are duly qualified
to do business and are in good standing in every jurisdiction in which its ownership of property or the nature of the business
conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified or be in good standing
would not have a Material Adverse Effect. As used in this Agreement, “Material Adverse Effect” means a change,
event, circumstance, effect or state of facts that has had or is reasonably likely to have, a material adverse effect on the business,
properties, assets, operations, results of operations, financial condition or prospects of the Company and its Subsidiaries, if
any, taken as a whole, or on the transactions contemplated hereby or by the agreements and instruments to be entered into in connection
herewith, or on the authority or ability of the Company to perform its obligations under the Transaction Documents.


 




    	 	8	 



     


    

 


4.2           AUTHORIZATION;
ENFORCEMENT; COMPLIANCE WITH OTHER INSTRUMENTS.


 


		i.	The Company has the requisite corporate power and authority
to enter into and perform Transaction Documents, and to issue the Securities in accordance with the terms hereof and thereof.



 


		ii.	The execution and delivery of the Transaction Documents
by the Company and the consummation by it of the transactions contemplated hereby and thereby, including without limitation the
issuance of the Securities pursuant to this Agreement, have been duly and validly authorized by the Company’s Board of Directors
and no further consent or authorization is required by the Company, its Board of Directors, or its shareholders.



 


		iii.	The Transaction Documents have been duly and validly executed
and delivered by the Company.



 


		iv.	The Transaction Documents constitute the valid and binding
obligations of the Company enforceable against the Company in accordance with their terms, except as such enforceability may be
limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar
laws relating to, or affecting generally, the enforcement of creditors’ rights and remedies.



 


4.3           CAPITALIZATION.
As of the date hereof, the authorized capital stock of the Company consists of 2,000,000,000 shares of the Common Stock, of which
as of November 28, 2016, 845,862,475 shares are issued and outstanding. All of such outstanding shares have been, or upon issuance
will be, validly issued and are fully paid and nonassessable. Except as disclosed in the SEC Documents or as otherwise set forth
on Schedule 4.3:


 


		i.	no shares of the Company’s capital stock are subject
to preemptive rights or any other similar rights or any liens or encumbrances suffered or permitted by the Company;



 


		ii.	there are no outstanding debt securities;



 


		iii.	there are no outstanding shares of capital stock, options,
warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings
or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional shares of capital stock
of the Company or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the Company or any of its Subsidiaries;



 


		iv.	there are no agreements or arrangements under which the
Company or any of its Subsidiaries is obligated to register the sale of any of their securities under the 1933 Act (except the
Registration Rights Agreement);



 


		v.	there are no outstanding securities of the Company or any
of its Subsidiaries which contain any redemption or similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any of its Subsidiaries is or may become bound to redeem a security of the Company or
any of its Subsidiaries;



 




    	 	9	 



     


    

 


		vi.	there are no securities or instruments containing anti-dilution
or similar provisions that will be triggered by the issuance of the Securities as described in this Agreement;



 


		vii.	the Company does not have any stock appreciation rights
or “phantom stock” plans or agreements or any similar plan or agreement; and



 


		viii.	there is no dispute as to the classification of any shares
of the Company’s capital stock.



 


The Company has furnished to the Investor,
or the Investor has had access through EDGAR to, true and correct copies of the Company’s Articles of Incorporation, as in
effect on the date hereof (the “Articles of Incorporation”), and the Company’s By-laws, as in effect on
the date hereof (the “By-laws”), and the terms of all securities convertible into or exercisable for Common
Stock and the material rights of the holders thereof in respect thereto.


 


4.4           ISSUANCE
OF SHARES. The Company has reserved the amount of Shares included in the Company’s Registration Statement for issuance
pursuant to the Transaction Documents, which have been duly authorized and reserved (subject to adjustment pursuant to the Company’s
covenant set forth in Section 5.5 below) pursuant to this Agreement. Upon issuance in accordance with this Agreement, the
Securities will be validly issued, fully paid for and non-assessable and free from all taxes, liens and charges with respect to
the issuance thereof. In the event the Company cannot register a sufficient number of Shares for issuance pursuant to this Agreement,
the Company will use its best efforts to authorize and reserve for issuance the number of Shares required for the Company to perform
its obligations hereunder as soon as reasonably practicable.


 


4.5           NO
CONFLICTS. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the
Company of the transactions contemplated hereby and thereby will not (i) result in a violation of the Articles of Incorporation,
any Certificate of Designations, Preferences and Rights of any outstanding series of preferred stock of the Company or the By-laws;
or (ii) conflict with, or constitute a material default (or an event which with notice or lapse of time or both would become a
material default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any material
agreement, contract, indenture mortgage, indebtedness or instrument to which the Company or any of its Subsidiaries is a party,
or to the Company’s knowledge result in a violation of any law, rule, regulation, order, judgment or decree (including United
States federal and state securities laws and regulations and the rules and regulations of the Principal Market or principal securities
exchange or trading market on which the Common Stock is traded or listed) applicable to the Company or any of its Subsidiaries
or by which any property or asset of the Company or any of its Subsidiaries is bound or affected. Neither the Company nor its Subsidiaries
is in violation of any term of, or in default under, the Articles of Incorporation, any Certificate of Designations, Preferences
and Rights of any outstanding series of preferred stock of the Company or the By-laws or their organizational charter or by-laws,
respectively, or any contract, agreement, mortgage, indebtedness, indenture, instrument, judgment, decree or order or any statute,
rule or regulation applicable to the Company or its Subsidiaries, except for possible conflicts, defaults, terminations, amendments,
accelerations, cancellations and violations that would not individually or in the aggregate have or constitute a Material Adverse
Effect. The business of the Company and its Subsidiaries is not being conducted, and shall not be conducted, in violation of any
law, statute, ordinance, rule, order or regulation of any governmental authority or agency, regulatory or self-regulatory agency,
or court, except for possible violations the sanctions for which either individually or in the aggregate would not have a Material
Adverse Effect. Except as specifically contemplated by this Agreement and as required under the 1933 Act or any securities laws
of any states, to the Company’s knowledge, the Company is not required to obtain any consent, authorization, permit or order
of, or make any filing or registration (except the filing of a registration statement as outlined in the Registration Rights Agreement
between the parties) with, any court, governmental authority or agency, regulatory or self-regulatory agency or other third party
in order for it to execute, deliver or perform any of its obligations under, or contemplated by, the Transaction Documents in accordance
with the terms hereof or thereof, other than such consents, authorizations, permits, orders, filings and registrations which have
been obtained or effected on or prior to the date hereof and are in full force and effect as of the date hereof. The Company and
its Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing. The Company is not, and
will not be, in violation of the listing requirements of the Principal Market as in effect on the date hereof and on each of the
Closing Dates and is not aware of any facts which would reasonably lead to delisting of the Common Stock by the Principal Market
in the foreseeable future.


 




    	 	10	 



     


    

 


4.6           
SEC DOCUMENTS; FINANCIAL STATEMENTS; MATERIAL NON-PUBLIC INFORMATION. As of the date hereof, the Company has filed all reports,
schedules, forms, statements and other documents required to be filed by it with the SEC pursuant to the reporting requirements
of the 1934 Act (all of the foregoing filed prior to the date hereof and all exhibits included therein and financial statements
and schedules thereto and documents incorporated by reference therein, and amendments thereto, being hereinafter referred to as
the “SEC Documents”). The Company has delivered to the Investor or its representatives, or they have had access
through EDGAR to, true and complete copies of the SEC Documents. As of their respective filing dates, the SEC Documents complied
in all material respects with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated thereunder
applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC or the time they were
amended, if amended, contained any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.
As of their respective dates, the financial statements of the Company included in the SEC Documents complied as to form in all
material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto.
Such financial statements have been prepared in accordance with generally accepted accounting principles, by a firm that is a member
of the Public Companies Accounting Oversight Board (“PCAOB”) consistently applied, during the periods involved
(except (i) as may be otherwise indicated in such financial statements or the notes thereto, or (ii) in the case of unaudited interim
statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present in all material
respects the financial position of the Company as of the dates thereof and the results of its operations and cash flows for the
periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments). No other written information
provided by or on behalf of the Company to the Investor which is not included in the SEC Documents, including, without limitation,
information referred to in Section 4.3 of this Agreement, contains any untrue statement of a material fact or omits to state
any material fact necessary to make the statements therein, in the light of the circumstance under which they are or were made,
not misleading. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
neither the Company nor any of its Subsidiaries or any of their officers, directors, employees or agents have provided the Investor
with any material, non-public information which was not publicly disclosed prior to the date hereof and any material, non-public
information provided to the Investor by the Company or its Subsidiaries or any of their officers, directors, employees or agents
prior to any Closing Date shall be publicly disclosed by the Company prior to such Closing Date.


 


4.7           ABSENCE
OF CERTAIN CHANGES. Except as otherwise set forth in the SEC Documents, the Company does not intend to change the business
operations of the Company in any material way. The Company has not taken any steps, and does not currently expect to take any steps,
to seek protection pursuant to any bankruptcy law nor does the Company or its Subsidiaries have any knowledge or reason to believe
that its creditors intend to initiate involuntary bankruptcy proceedings.


 




    	 	11	 



     


    

 


4.8           ABSENCE
OF LITIGATION AND/OR REGULATORY PROCEEDINGS. Except as set forth in the SEC Documents, there is no action, suit, proceeding,
inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending
or, to the knowledge of the executive officers of Company or any of its Subsidiaries, threatened against or affecting the Company,
the Common Stock or any of the Company’s Subsidiaries or any of the Company’s or the Company’s Subsidiaries’
officers or directors in their capacities as such, in which an adverse decision could have a Material Adverse Effect.


 


4.9           ACKNOWLEDGMENT
REGARDING INVESTOR’S PURCHASE OF SHARES. The Company acknowledges and agrees that the Investor is acting solely in the
capacity of an arm’s length Investor with respect to the Transaction Documents and the transactions contemplated hereby and
thereby. The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company (or
in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby and thereby and any
advice given by the Investor or any of its respective representatives or agents in connection with the Transaction Documents and
the transactions contemplated hereby and thereby is merely incidental to the Investor’s purchase of the Securities, and is
not being relied on by the Company. The Company further represents to the Investor that the Company’s decision to enter into
the Transaction Documents has been based solely on the independent evaluation by the Company and its representatives.


 


4.10         NO
UNDISCLOSED EVENTS, LIABILITIES, DEVELOPMENTS OR CIRCUMSTANCES. Except as set forth in the SEC Documents and except for the
transactions contemplated by the Transaction Documents, as of the date hereof, no event, liability, development or circumstance
has occurred or exists, or to the Company’s knowledge is contemplated to occur, with respect to the Company or its Subsidiaries
or their respective business, properties, assets, prospects, operations or financial condition, that would be required to be disclosed
by the Company under applicable securities laws and which has not been publicly announced.


 


4.11         INTELLECTUAL
PROPERTY RIGHTS. The Company and its Subsidiaries own or possess adequate rights or licenses to use all trademarks, trade names,
service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, trade secrets
and rights necessary to conduct their respective businesses as now conducted. Except as set forth in the SEC Documents or as otherwise
set forth on Schedule 4.11, none of the Company’s trademarks, trade names, service marks, service mark registrations, service
names, patents, patent rights, copyrights, inventions, licenses, trade secrets or other intellectual property rights necessary
to conduct its business as now or as proposed to be conducted have expired or terminated, or are expected to expire or terminate
within two (2) years from the date of this Agreement. The Company and its Subsidiaries do not have any knowledge of any infringement
by the Company or its Subsidiaries of trademark, trade name rights, patents, patent rights, copyrights, inventions, licenses, service
names, service marks, service mark registrations, trade secret or other similar rights of others, and, except as set forth in the
SEC Documents, there is no claim, action or proceeding being made or brought against, or to the Company’s knowledge, being
threatened against, the Company or its Subsidiaries regarding trademark, trade name, patents, patent rights, invention, copyright,
license, service names, service marks, service mark registrations, trade secret or other infringement; and the Company and its
Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing. The Company and its Subsidiaries
have taken commercially reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual
properties.


 




    	 	12	 



     


    

 


4.12         TITLE.
The Company and its Subsidiaries have good and marketable title to all personal property owned by them which is material to the
business of the Company and its Subsidiaries, in each case free and clear of all liens, encumbrances and defects except such as
are described in the SEC Documents or such as do not materially affect the value of such property and do not interfere with the
use made and proposed to be made of such property by the Company or any of its Subsidiaries. Any real property and facilities held
under lease by the Company or any of its Subsidiaries are held by them under valid, subsisting and enforceable leases with such
exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by
the Company and its Subsidiaries.


 


4.13         DILUTIVE
EFFECT. The Company understands and acknowledges that the number of shares of Common Stock issuable upon purchases pursuant
to this Agreement will increase in certain circumstances including, but not necessarily limited to, the circumstance wherein the
trading price of the Common Stock declines during the period between the Effective Date and the end of the Open Period. The Company’s
management has studied and fully understand the nature of the transactions contemplated by this Agreement and recognize that they
have a potential dilutive effect on the shareholders of the Company. The Company specifically acknowledges that, subject to such
limitations as are expressly set forth in the Transaction Documents, its obligation to issue shares of Common Stock upon purchases
pursuant to this Agreement is absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership
interests of other shareholders of the Company.


 


4.14         NO
GENERAL SOLICITATION. Neither the Company, nor any of its affiliates, nor any person acting on its behalf, has engaged in any
form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale of
the Common Stock to be offered as set forth in this Agreement.


 


4.15         NO
BROKERS, FINDERS OR FINANCIAL ADVISORY FEES OR COMMISSIONS. No brokers, finders or financial advisory fees or commissions will
be payable by the Company, its agents or Subsidiaries, with respect to the transactions contemplated by this Agreement.


 


4.16         EXCLUSIVITY.
The Company shall not pursue a similar Equity Financing transaction with any other party unless and until good faith negotiations
have terminated between the Investor and the Company or until such time as the registration statement has been declared effective
by the SEC.


 


4.17         INTERNAL
ACCOUNTING CONTROLS. Except as otherwise set forth in the SEC Documents, the Company and each of its Subsidiaries maintain
a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance
with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of
financial statements in conformity with generally accepted accounting principles by a firm with membership to the PCAOB and to
maintain asset accountability; (iii) access to assets is permitted only in accordance with management’s general or specific
authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and
appropriate action is taken with respect to any differences. The Company’s management has determined that the Company’s
internal accounting controls were not effective as of the date of this Agreement as further described in the SEC Documents.


 




    	 	13	 



     


    

 


4.18         TAX
STATUS. Except as otherwise set forth on Schedule 4.18, the Company and each of its Subsidiaries has made or filed all United
States federal and state income and all other tax returns, reports and declarations required by any jurisdiction to which it is
subject (unless and only to the extent that the Company and each of its Subsidiaries has set aside on its books provisions reasonably
adequate for the payment of all unpaid and unreported taxes) and has paid all taxes and other governmental assessments and charges
that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being contested
in good faith and has set aside on its books provision reasonably adequate for the payment of all taxes for periods subsequent
to the periods to which such returns, reports or declarations apply. Except as otherwise set forth on Schedule 4.18, there are
no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
know of no basis for any such claim.


 


4.19         CERTAIN
TRANSACTIONS. Except as set forth in the SEC Documents filed at least ten (10) days prior to the date hereof or as otherwise
set forth on Schedule 4.19 and except for arm’s length transactions pursuant to which the Company makes payments in the ordinary
course of business upon terms no less favorable than the Company could obtain from disinterested third parties, none of the officers,
directors or employees of the Company is presently a party to any transaction with the Company or any of its Subsidiaries (other
than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the
furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments
to or from any officer, director or such employee or, to the knowledge of the Company, any corporation, partnership, trust or other
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner,
such that disclosure would be required in the SEC Documents.


 


SECTION V


COVENANTS OF THE COMPANY


 


5.1           BEST
EFFORTS. The Company shall use all commercially reasonable efforts to timely satisfy each of the conditions set forth in Section
7 of this Agreement.


 


5.2           REPORTING
STATUS. Until one of the following occurs, the Company shall file all reports required to be filed with the SEC pursuant to
the 1934 Act, and the Company shall not terminate its status, or take an action or fail to take any action, which would terminate
its status as a reporting company under the 1934 Act: (i) this Agreement terminates pursuant to Section 8 and the Investor
has the right to sell all of the Securities without restrictions pursuant to Rule 144 promulgated under the 1933 Act, or such other
exemption, or (ii) the date on which the Investor has sold all the Securities and this Agreement has been terminated pursuant to
Section 8.


 


5.3           USE
OF PROCEEDS. The Company will use the proceeds from the sale of the Shares (excluding amounts paid by the Company for fees
as set forth in the Transaction Documents) for general corporate and working capital purposes and/or acquisitions of assets, businesses
or operations and/or for other purposes that the Board of Directors, in its good faith deem to be in the best interest of the Company.


 


5.4           FINANCIAL
INFORMATION. During the Open Period, the Company agrees to make available to the Investor via EDGAR or other electronic means
the following documents and information on the forms set forth: (i) within five (5) Trading Days after the filing thereof with
the SEC, a copy of its Annual Reports on Form 10-K, its Quarterly Reports on Form 10-Q, any Current Reports on Form 8-K and any
Registration Statements or amendments filed pursuant to the 1933 Act; (ii) copies of any notices and other information made available
or given to the shareholders of the Company generally, contemporaneously with the making available or giving thereof to the shareholders;
and (iii) within two (2) calendar days of filing or delivery thereof, copies of all documents filed with, and all correspondence
sent to, the Principal Market, any securities exchange or market, or the Financial Industry Regulatory Association, unless such
information is material non-public information.


 




    	 	14	 



     


    

 


5.5           RESERVATION
OF SHARES. The Company shall take all action necessary to at all times have authorized, and reserved the amount of Shares included
in the Company’s Registration Statement for issuance pursuant to the Transaction Documents. In the event that the Company
determines that it does not have a sufficient number of authorized shares of Common Stock to reserve and keep available for issuance
as described in this Section 5.5, the Company shall use all commercially reasonable efforts to increase the number of authorized
shares of Common Stock by seeking shareholder approval for the authorization of such additional shares.


 


5.6           LISTING.
The Company shall promptly secure and maintain the listing of all of the Registrable Securities on the Principal Market and each
other national securities exchange and automated quotation system, if any, upon which shares of Common Stock are then listed (subject
to official notice of issuance) and shall maintain such listing of all Registrable Securities from time to time issuable under
the terms of the Transaction Documents. Neither the Company nor any of its Subsidiaries shall take any action which would be reasonably
expected to result in the delisting or suspension of the Common Stock on the Principal Market (excluding suspensions of not more
than one (1) Trading Day resulting from business announcements by the Company). The Company shall promptly provide to the Investor
copies of any notices it receives from the Principal Market regarding the continued eligibility of the Common Stock for listing
on such automated quotation system or securities exchange. The Company shall pay all fees and expenses in connection with satisfying
its obligations under this Section 5.6.


 


5.7           FILING
OF FORM 8-K. On or before the date which is four (4) Trading Days after the Execution Date, the Company shall file a Current
Report on Form 8-K with the SEC describing the terms of the transaction contemplated by the Transaction Documents in the form required
by the 1934 Act, if such filing is required.


 


5.8           CORPORATE
EXISTENCE. The Company shall use all commercially reasonable efforts to preserve and continue the corporate existence of the
Company.


 


5.9           NOTICE
OF CERTAIN EVENTS AFFECTING REGISTRATION; SUSPENSION OF RIGHT TO MAKE A PUT. The Company shall promptly notify the Investor
upon the occurrence of any of the following events in respect of a Registration Statement or related prospectus in respect of an
offering of the Securities: (i) receipt of any request for additional information by the SEC or any other federal or state governmental
authority during the period of effectiveness of the Registration Statement for amendments or supplements to the Registration Statement
or related prospectus; (ii) the issuance by the SEC or any other federal or state governmental authority of any stop order suspending
the effectiveness of any Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt of any notification
with respect to the suspension of the qualification or exemption from qualification of any of the Securities for sale in any jurisdiction
or the initiation or notice of any proceeding for such purpose; (iv) the happening of any event that makes any statement made in
such Registration Statement or related prospectus or any document incorporated or deemed to be incorporated therein by reference
untrue in any material respect or that requires the making of any changes in the Registration Statement, related prospectus or
documents so that, in the case of a Registration Statement, it will not contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary to make the statements therein not misleading, and that in
the case of the related prospectus, it will not contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading; and (v) the Company’s reasonable determination that a post-effective amendment or supplement to the
Registration Statement would be appropriate, and the Company shall promptly make available to Investor any such supplement or amendment
to the related prospectus. The Company shall not deliver to Investor any Put Notice during the continuation of any of the foregoing
events in this Section 5.9.


 




    	 	15	 



     


    

 


5.10         TRANSFER
AGENT. Upon effectiveness of the Registration Statement, and for so long as the Registration Statement is effective, following
delivery of a Put Notice, the Company shall, in connection with any Closing, deliver instructions to its transfer agent to issue
Shares to the Investor that are covered for resale by the Registration Statement free of restrictive legends.


 


5.11         ACKNOWLEDGEMENT
OF TERMS. The Company hereby represents and warrants to the Investor that: (i) it is voluntarily entering into this Agreement
of its own freewill, (ii) it is not entering this Agreement under economic duress, (iii) the terms of this Agreement are reasonable
and fair to the Company, and (iv) the Company has had independent legal counsel of its own choosing review this Agreement, advise
the Company with respect to this Agreement, and represent the Company in connection with this Agreement.


 


SECTION VI


CONDITIONS OF THE COMPANY’S OBLIGATION
TO SELL


 


The obligation hereunder
of the Company to issue and sell the Securities to the Investor is further subject to the satisfaction, at or before each Closing
Date, of each of the following conditions set forth below. These conditions are for the Company’s sole benefit and may be
waived by the Company at any time in its sole discretion.


 


6.1           The
Investor shall have executed this Agreement and the Registration Rights Agreement and delivered the same to the Company.


 


6.2           The
representations and warranties of the Investor shall be true and correct as of the date when made and as of the applicable Closing
Date as though made at that time and the Investor shall have performed, satisfied and complied with the covenants, agreements and
conditions required by the Transaction Documents to be performed, satisfied or complied with by the Investor on or before such
Closing Date.


 


6.3           The
Investor shall have delivered to the Company the Put Amount for the Securities being purchased by the Investor at such Closing.


 


6.4           No
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated
by this Agreement.


 


SECTION VII


FURTHER CONDITIONS OF THE INVESTOR’S
OBLIGATION TO PURCHASE


 


The obligation of the
Investor hereunder to purchase Securities is subject to the satisfaction, on or before each Closing Date, of each of the following
conditions set forth below.


 


7.1           The
Company shall have executed the Transaction Documents and delivered the same to the Investor.


 




    	 	16	 



     


    

 


7.2           The
representations and warranties of the Company shall be true and correct as of the date when made and the representation contained
in Section 4.3 shall be true and correct as of the applicable Closing Date as though made at that time and the Company shall
have performed, satisfied and complied with the covenants, agreements and conditions required by the Transaction Documents to be
performed, satisfied or complied with by the Company on or before such Closing Date. The Investor may request an update as of such
Closing Date regarding the representation contained in Section 4.3.


 


7.3           The
Company shall have executed and delivered to the Investor the certificates representing, or have executed electronic book-entry
transfer of, the Securities (in such denominations as the Investor shall request) being purchased by the Investor at such Closing.


 


7.4           The
Board of Directors of the Company shall have adopted resolutions consistent with Section 4.2(ii) (the “Resolutions”)
and such Resolutions shall not have been amended or rescinded prior to such Closing Date.


 


7.5           No
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated
by this Agreement.


 


7.6           The
Registration Statement shall be effective in accordance with the Registration Rights Agreement on each Closing Date and no stop
order suspending the effectiveness of the Registration Statement shall be in effect or to the Company’s knowledge shall be
pending or threatened. Furthermore, on each Closing Date (I) neither the Company nor the Investor shall have received notice that
the SEC has issued or intends to issue a stop order with respect to such Registration Statement or that the SEC otherwise has suspended
or withdrawn the effectiveness of such Registration Statement, either temporarily or permanently, or intends or has threatened
to do so (unless the SEC’s concerns have been addressed), and (II) no other suspension of the use or withdrawal of the effectiveness
of such Registration Statement or related prospectus shall exist.


 


7.7           At
the time of each Closing, the Registration Statement (including information or documents incorporated by reference therein) and
any amendments or supplements thereto shall not contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein not misleading or which would require public disclosure
or an update supplement to the prospectus.


 


7.8           If
applicable, the shareholders of the Company shall have approved the issuance of any Shares in excess of the Maximum Common Stock
Issuance in accordance with Section 2.6 or the Company shall have obtained appropriate approval pursuant to the requirements
of applicable law and the Company’s Articles of Incorporation and By-laws.


 


7.9           The
conditions to such Closing set forth in Section 2.4 shall have been satisfied on or before such Closing Date.


 


7.10         The
Company shall have certified to the Investor the number of Shares of Common Stock outstanding when a Put Notice is given to the
Investor. The Company’s delivery of a Put Notice to the Investor constitutes the Company’s certification of the existence
of the necessary number of shares of Common Stock reserved for issuance.


 




    	 	17	 



     


    

 


SECTION VIII


TERMINATION


 


This Agreement shall terminate
upon any of the following events:


 


8.1           when
the Investor has purchased an aggregate of Seven Million Dollars ($7,000,000) in the Common Stock of the Company pursuant to this
Agreement; or


 


8.2           on
the date which is twenty-four (24) months after the Effective Date; or


 


8.3           upon
the issuance by the SEC or any other federal or state governmental authority of any stop order suspending the effectiveness of
any Registration Statement; or


 


8.4           seven
(7) calendar days from the date of Company’s written notice of termination.


 


Any and all Shares and/or
amounts due under this Agreement prior to the termination date, but not yet paid and/or delivered, shall be immediately payable
and due upon termination of this Agreement.


 


SECTION IX


SUSPENSION


 


This Agreement shall be
suspended upon any of the following events, and shall remain suspended until such event is rectified:


 


		i.	The trading of the Common Stock is suspended by the SEC,
the Principal Market or FINRA for a period of two (2) consecutive Trading Days during the Open Period; or



 


		ii.	The Common Stock ceases to be quoted, listed or traded
on a Trading Market or, the Registration Statement is no longer effective (except as permitted hereunder or as a result of any
Investor’s Delay).



 


		iii.	Immediately upon the occurrence of one of the above-described
events, the Company shall send written notice of such event to the Investor, unless such information is material non-public information
in which case the Company shall file a current report on Form 8-K within four business days.



 


SECTION X


INDEMNIFICATION


 


In consideration of the
parties mutual obligations set forth in the Transaction Documents, the Company ( the “Indemnitor”) shall defend,
protect, indemnify and hold harmless the Investor and all of the investor’s shareholders, officers, directors, employees,
counsel, and any of the foregoing person’s agents or other representatives (including, without limitation, those retained
in connection with the transactions contemplated by this Agreement) (collectively, the “Indemnitees”) from and
against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and reasonable
expenses in connection therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification
hereunder is sought), and including reasonable attorneys’ fees and disbursements (the “Indemnified Liabilities”),
incurred by any Indemnitee as a result of, or arising out of, or relating to (I) any misrepresentation or breach of any representation
or warranty made by the Indemnitor in the Transaction Documents; (II) any breach of any covenant, agreement or obligation of the
Indemnitor contained in the Transaction Documents; or (III) any cause of action, suit or claim brought or made against such Indemnitee
by a third party and arising out of or resulting from the execution, delivery, performance or enforcement of the Transaction Documents
(unless such action, suit or claim is based upon a breach of Investor’s representations, warranties or covenants under the
Transaction Documents or any conduct by such Indemnitees which constitutes fraud, gross negligence, willful misconduct or malfeasance),
except insofar as any such misrepresentation, breach or any untrue statement, alleged untrue statement, omission or alleged omission
is made in reliance upon and in conformity with information furnished to Indemnitor which is specifically intended for use in the
preparation of any such Registration Statement, preliminary prospectus, prospectus or amendments to the prospectus. To the extent
that the foregoing undertaking by the Indemnitor may be unenforceable for any reason, the Indemnitor shall make the maximum contribution
to the payment and satisfaction of each of the Indemnified Liabilities which is permissible under applicable law. The indemnity
provisions contained herein shall be in addition to any cause of action or similar rights Indemnitor may have, and any liabilities
the Indemnitor or the Indemnitees may be subject to.


 




    	 	18	 



     


    

 


SECTION XI


MISCELLANEOUS


 


11.1         Law
Governing this Agreement. This Agreement shall be governed by and construed in accordance with the laws of the State
of New York without regard to principles of conflicts of laws. Any action brought by either party against the other concerning
the transactions contemplated by this Agreement shall be brought only in the state or federal courts located in the City and State
of New York. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted
hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The
parties executing this Agreement and other agreements referred to herein or delivered in connection herewith on behalf of the Company
agree to submit to the in personam jurisdiction of such courts and hereby irrevocably waive trial by jury. The prevailing party
shall be entitled to recover from the other party its reasonable attorney’s fees and costs. Each party hereby irrevocably
waives personal service of process and consents to process being served in any suit, action or proceeding in connection with this
Agreement or any other Transaction Documents by mailing a copy thereof via registered or certified mail or overnight delivery (with
evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in
any way any right to serve process in any other manner permitted by law.


 


11.2         LEGAL
FEES; AND MISCELLANEOUS FEES. Except as otherwise set forth in the Transaction Documents (including but not limited to Section
V of the Registration Rights Agreement), each party shall pay the fees and expenses of its advisers, counsel, the accountants and
other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery
and performance of this Agreement. Any attorneys’ fees and expenses incurred by either the Company or the Investor in connection
with the preparation, negotiation, execution and delivery of any amendments to this Agreement or relating to the enforcement of
the rights of any party, after the occurrence of any breach of the terms of this Agreement by another party or any default by another
party in respect of the transactions contemplated hereunder, shall be paid on demand by the party which breached the Agreement
and/or defaulted, as the case may be. The Company shall pay all stamp and other taxes and duties levied in connection with the
issuance of any Securities.


 


11.3         COUNTERPARTS.
This Agreement may be executed in any number of counterparts and by the different signatories hereto on separate counterparts,
each of which, when so executed, shall be deemed an original, but all such counterparts shall constitute but one and the same instrument.
This Agreement may be executed by facsimile transmission, PDF, electronic signature or other similar electronic means with the
same force and effect as if such signature page were an original thereof.


 




    	 	19	 



     


    

 


11.4         HEADINGS;
SINGULAR/PLURAL. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the
interpretation of, this Agreement. Whenever required by the context of this Agreement, the singular shall include the plural and
masculine shall include the feminine.


 


11.5         SEVERABILITY.
In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or unenforceable
under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict
therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid
or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.


 


11.6         ENTIRE
AGREEMENT; AMENDMENTS. This Agreement is the FINAL AGREEMENT between the Company and the Investor with respect to the terms
and conditions set forth herein, and, the terms of this Agreement may not be contradicted by evidence of prior, contemporaneous,
or subsequent oral agreements of the Parties. No provision of this Agreement may be amended other than by an instrument in writing
signed by the Company and the Investor, and no provision hereof may be waived other than by an instrument in writing signed by
the party against whom enforcement is sought. The execution and delivery of the Transaction Documents shall not alter the force
and effect of any other agreements between the Parties, and the obligations under those agreements.


 


11.7         NOTICES.
Any notices or other communications required or permitted to be given under the terms of this Agreement must be in writing and
will be deemed to have been delivered (I) upon receipt, when delivered personally; (II) upon receipt, when sent by facsimile (provided
confirmation of transmission is mechanically or electronically generated and kept on file by the sending party); or (III) one (1)
day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive
the same. The addresses and facsimile numbers for such communications shall be:


 


	If to the Company:	 	Propanc Health Group Corporation
	 	 	Attn: James Nathanielsz, CEO
	 	 	302, 6 Butler Street
	 	 	Camberwell, VIC 3124
	 	 	Australia
	 	 	Fax: +6139882-9969
	 	 	 
	With a copy to	 	Harter Secrest & Emery LLP
	(which shall not constitute notice):	 	Attn: Alexander R. McClean, Esq.
	 	 	1600 Bausch & Lomb Place
	 	 	Rochester, New York 14604
	 	 	Fax: (585) 232-2152 
	 	 	 
	If to the Investor:	 	GHS Investments, LLC
	 	 	200 Stonehinge Lane, 
	 	 	Suite 3
	 	 	Carle Place, NY 11514
	 	 	Fax: (212) 574-3326


 




    	 	20	 



     


    

 


Each party shall provide five (5) days
prior written notice to the other party of any change in address or facsimile number.


 


11.8         NO
ASSIGNMENT. This Agreement may not be assigned.


 


11.9         NO
THIRD PARTY BENEFICIARIES. This Agreement is intended for the benefit of the parties hereto and is not for the benefit of,
nor may any provision hereof be enforced by, any other person, except that the Company acknowledges that the rights of the Investor
may be enforced by its general partner.


 


11.10       SURVIVAL.
The representations, warranties and covenants of the Company and the Investor contained in Sections 3, 4, 5 and 12, and the indemnification
provisions set forth in Section 10, shall survive each of the Closings and the termination of this Agreement.


 


11.11       PUBLICITY.
The Investor acknowledges that this Agreement and all or part of the Transaction Documents may be deemed to be “material
contracts” as that term is defined by Item 601(b)(10) of Regulation S-K, and that the Company may therefore be required to
file such documents as exhibits to reports or registration statements filed under the 1933 Act or the 1934 Act. The Investor further
agrees that the status of such documents and materials as material contracts shall be determined solely by the Company, in consultation
with its counsel.


 


11.12       FURTHER
ASSURANCES. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.


 


11.13       NO
STRICT CONSTRUCTION. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party, as the parties mutually agree that
each has had a full and fair opportunity to review this Agreement and seek the advice of counsel on it.


 


11.14       REMEDIES.
The Investor shall have all rights and remedies set forth in this Agreement and the Registration Rights Agreement and all rights
and remedies which such holders have been granted at any time under any other agreement or contract and all of the rights which
the Investor has by law. Any person having any rights under any provision of this Agreement shall be entitled to enforce such rights
specifically (without posting a bond or other security), to recover damages by reason of any default or breach of any provision
of this Agreement, including the recovery of reasonable attorneys fees and costs, and to exercise all other rights granted by law.


 


11.15       PAYMENT
SET ASIDE. To the extent that the Company makes a payment or payments to the Investor hereunder or under the Registration Rights
Agreement or the Investor enforces or exercises its rights hereunder or thereunder, and such payment or payments or the proceeds
of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set
aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver
or any other person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable
cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied
shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had
not occurred.


 




    	 	21	 



     


    

 


11.16       PRICING
OF COMMON STOCK. For purposes of this Agreement, the price of the Common Stock shall be as reported in the principal consolidated
transaction reporting system for the Common Stock or, if unavailable, as
reported by Bloomberg, L.P.


 


SECTION XII


NON-DISCLOSURE OF NON-PUBLIC INFORMATION


 


Except with respect to
the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company shall not disclose
material non-public information to the Investor, its advisors, or its representatives unless prior thereto the Investor shall have
consented in writing.


 


Except as expressly provided
otherwise in this Agreement, nothing herein shall require the Company to disclose material non-public information to the Investor
or its advisors or representatives. Nothing contained in this Section 12 shall be construed to mean that the advisors and
representatives of the Investor (and the Investor with the written consent of the Investor prior to disclosure of such information)
may not obtain material non-public information in the course of conducting due diligence in accordance with the terms of this Agreement,
and nothing herein shall prevent any such persons or entities from notifying the Company of their opinion that based on such due
diligence by such persons or entities, that the Registration Statement contains an untrue statement of material fact or omits a
material fact required to be stated in the Registration Statement or necessary to make the statements contained therein, in light
of the circumstances in which they were made, not misleading.


 


SECTION XIII


ACKNOWLEDGEMENTS OF THE PARTIES


 


Notwithstanding anything
in this Agreement to the contrary, the parties hereto hereby acknowledge and agree to the following: (i) the Investor makes no
representations or covenants that it will not engage in trading in the securities of the Company, other than the Investor will
not engage in any Short Sales of the Company’s securities at any time during this Agreement; (ii) the Company shall, by 9:30
a.m. EST on the fourth Trading Day following the date hereof, file a current report on Form 8-K disclosing the material terms of
the transactions contemplated hereby and in the other Transaction Documents; (iii) except with respect to the material terms and
conditions of the transactions contemplated by the Transaction Documents, the Company has not and shall not provide material non-public
information to the Investor unless prior thereto the Investor shall have executed a written agreement regarding the confidentiality
and use of such information; and (iv) the Company understands and confirms that the Investor will be relying on the acknowledgements
set forth in clauses (i) through (iii) above if the Investor effects any transactions in the securities of the Company (other than
any Short Sales of the Company’s securities).


 


[Signature page follows]


 




    	 	22	 



     


    

 


Your signature on this
Signature Page evidences your agreement to be bound by the terms and conditions of the Agreement as of the date first written above.
The undersigned signatory hereby certifies that he has read and understands the Agreement, and the representations made by the
undersigned in this Agreement are true and accurate, and agrees to be bound by its terms.


 


	 	GHS INVESTMENTS, LLC
	 	 	 
	 	By: 	 
	 	Name: ____________
	 	Title: _____________
	 	 	 
	 	PROPANC HEALTH GROUP CORPORATION
	 	 	 
	 	By: 	 
	 	Name:  James Nathanielsz
	 	Title: Chief Executive Officer


 


[SIGNATURE PAGE OF EQUITY FINANCING AGREEMENT]


 




    	 	23